Interestingly, the extracellular vesicles as a serum marker of α-synuclein were already obtained from individuals with high-risk PD, and the total α-synuclein level was found to be increased in RBD and individuals with high-risk PD [104]. This evidence concerns the gene SNCA and Parkinson disease.